Mark Tekrony
Neurology · Reston, VANPI 1386613826
Payments from drug & device makers
Across 285 payments — averaging $13.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$772
- Harmony Biosciences LLC$309
- Jazz Pharmaceuticals Inc.$262
- Lundbeck LLC$179
- Lilly USA, LLC$118
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,783100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 152 | $1,002 |
| AbbVie(2 entities) | 43 | $772 |
| Harmony Biosciences LLC | 13 | $309 |
| Jazz Pharmaceuticals Inc. | 10 | $262 |
| Lundbeck LLC | 9 | $179 |
| Lilly USA, LLC | 6 | $118 |
| Merz Pharmaceuticals, LLC | 5 | $114 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $86 |
| Novartis | 5 | $86 |
| Supernus Pharmaceuticals, Inc. | 3 | $69 |
| Eisai Inc. | 3 | $64 |
| Argenx US, Inc. | 2 | $56 |
| Pfizer | 3 | $55 |
| Idorsia Pharmaceuticals US Inc | 2 | $49 |
| UCB, Inc. | 2 | $47 |
| AstraZeneca(2 entities) | 2 | $44 |
| Revance Therapeutics, Inc. | 1 | $39 |
| Life Molecular Imaging Ltd | 1 | $37 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Upsher-smith Laboratories LLC | 1 | $31 |
| TG Therapeutics, Inc. | 1 | $28 |
| Noctrix Health, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $24 |
| Amgen | 2 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| Biogen | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
| Itamar Medical Inc | 1 | $12 |
How this compares
$3,794 in reported general payments places this provider in the 60th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 18 | $20,208 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,869 |
| Gabapentin | 161 | $3,069 |
| Duloxetine Hcl | 79 | $2,104 |
| Oxcarbazepine | 22 | $1,361 |
| Propranolol Hcl ErPropranolol Hcl | 37 | $1,219 |
| Pregabalin | 22 | $1,115 |
| Levetiracetam | 20 | $837 |
| Pyridostigmine Bromide | 11 | $623 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 15 | $558 |
| Donepezil Hcl | 22 | $529 |
| Escitalopram Oxalate | 17 | $510 |
| Nortriptyline Hcl | 27 | $447 |
| Ropinirole Hcl | 26 | $394 |
| Propranolol Hcl | 18 | $319 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $772 | $20,20818 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $17 | $62311 claims |
| Upsher-smith Laboratories LLCTopiramate | $31 | $15711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 474 neurology providers in Virginia.
Other neurology in Reston
- Michelle BetzVirginia Beach$3.3M
- Daniel CohenNorfolk$2.9M
- Heidi CraytonVienna$2.5M
- Ramsey FalconerAlexandria$2.4M
- Robert ShinCharlottesville$2.2M
- Simon FishmanAlexandria$1.6M
- Ingrid Loma MillerNorfolk$1.2M
- Matthew BarrettHenrico$1.1M
- James BickselMc Lean$1M
- Rahul DaveFairfax$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.